Sign in or Register   Sign in or Register
  |  

Mouse Anti-GSTM1 Antibody (7BA3) (CBMAB-1306CQ)

This product is a mouse antibody that recognizes GSTM1. The antibody 7BA3 can be used for immunoassay techniques such as: ELISA, IHC-P, IHC, MA, WB.
See all GSTM1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
7BA3
Antibody Isotype
IgG2a
Application
ELISA, IHC-P, IHC, MA, WB

Basic Information

Immunogen
Recombinant full length protein
Specificity
Human
Antibody Isotype
IgG2a
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Supernatant
Purity
>95% as determined by analysis by SDS-PAGE
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
glutathione S-transferase mu 1
Introduction
This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. Diseases associated with GSTM1 include Lung Cancer, Gstm1-Related and Lung Cancer.
Entrez Gene ID
2944
UniProt ID
P09488
Alternative Names
GSTM1; MU; H-B; GST1; GTH4; GTM1; MU-1; GSTM1-1; GSTM1a-1a; GSTM1b-1b
Function
Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Involved in the formation of glutathione conjugates of both prostaglandin A2 (PGA2) and prostaglandin J2 (PGJ2) (PubMed:9084911).

Participates in the formation of novel hepoxilin regioisomers (PubMed:21046276).
Biological Process
Cellular detoxification of nitrogen compound Source: BHF-UCL
Glutathione derivative biosynthetic process Source: UniProtKB
Glutathione metabolic process Source: BHF-UCL
Hepoxilin biosynthetic process Source: UniProtKB
Nitrobenzene metabolic process Source: BHF-UCL
Prostaglandin metabolic process Source: UniProtKB
Xenobiotic catabolic process Source: BHF-UCL
Cellular Location
Cytoplasm

Nakanishi, G., Bertagnolli, L. S., Pita-Oliveira, M., Scudeler, M. M., Torres-Loureiro, S., Almeida-Dantas, T., ... & Rodrigues-Soares, F. (2022). GSTM1 and GSTT1 polymorphisms in healthy volunteers–a worldwide systematic review. Drug Metabolism Reviews, 54(1), 37-45.

Levy, R. V., Reidy, K. J., Le, T. H., David, V., Winkler, C., Xu, Y., ... & Melamed, M. L. (2022). Association of GSTM1 deletion with progression of CKD in children: Findings from the chronic kidney disease in children (CKiD) study. American Journal of Kidney Diseases, 80(1), 79-86.

Abbas, M., Verma, S., Verma, S., Siddiqui, S., Khan, F. H., Raza, S. T., ... & Mahdi, F. (2021). Association of GSTM1 and GSTT1 gene polymorphisms with COVID‐19 susceptibility and its outcome. Journal of medical virology, 93(9), 5446-5451.

Singh, P., Wang, X., Hageman, L., Chen, Y., Magdy, T., Landier, W., ... & Bhatia, S. (2020). Association of GSTM1 null variant with anthracycline‐related cardiomyopathy after childhood cancer—A Children's Oncology Group ALTE03N1 report. Cancer, 126(17), 4051-4058.

Chanhom, N., Udomsinprasert, W., Mahasirimongkol, S., Wattanapokayakit, S., & Jittikoon, J. (2020). GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug‑induced liver injury. Biomedical Reports, 12(4), 153-162.

Song, L., Yang, C., & He, X. F. (2020). Individual and combined effects of GSTM1 and GSTT1 polymorphisms on colorectal cancer risk: an updated meta-analysis. Bioscience Reports, 40(8).

Li, S., Xue, F., Zheng, Y., Yang, P., Lin, S., Deng, Y., ... & Chen, S. (2019). GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies. Cancer cell international, 19(1), 1-12.

Kalacas, N. A., Garcia, J. A., Ortin, T. S., Valdez Jr, A., Fellizar, A., Ramos, M. C., & Albano, P. M. (2019). GSTM1 and GSTT1 genetic polymorphisms and breast cancer risk in selected Filipino cases. Asian Pacific journal of cancer prevention: APJCP, 20(2), 529.

Grubisa, I., Otasevic, P., Vucinic, N., Milicic, B., Jozic, T., Krstic, S., & Milasin, J. (2018). Combined GSTM1 and GSTT1 null genotypes are strong risk factors for atherogenesis in a Serbian population. Genetics and molecular biology, 41, 35-40.

Klusek, J., Nasierowska-Guttmejer, A., Kowalik, A., Wawrzycka, I., Lewitowicz, P., Chrapek, M., & Głuszek, S. (2018). GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers. Oncotarget, 9(30), 21224.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-GSTM1 Antibody (7BA3)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare